Leading figures in psychiatry acknowledge that DSM psychiatric diagnoses and the chemical imbalance theory of mental illness are not scientifically valid, but are useful fictions that help people manage their emotions and comply with their medication treatments.
Researchers suggest that antidepressant withdrawal can be a possible precipitant of suicide.
A study finds that commonly prescribed antidepressants are associated with the development of diabetes, hypertension, and other diseases.
We talk with author Beverley Thomson about her latest book, entitled Antidepressed: A Breakthrough Examination of Epidemic Antidepressant Harm and Dependence.
Peter Simons covers in detail a new systematic review that debunks the widely popularized myth of low serotonin in depression, the “chemical imbalance theory.”
Researchers found that 25% of elderly patients taking antidepressants had serotonin syndrome, which is potentially life-threatening.
Peter Simons covers news on mental health app Cerebral and pharma companies Biogen and Cassava; how social media influencers are the new pharma marketers; studies that found antidepressants don't improve quality of life and are harmful to the fetus when pregnant women take them; benzo withdrawal; and more!
The problems related to the use of antidepressants cannot be solved by an oversimplified psychiatry brainwashed by the pharmaceutical industry.
Peter Simons covers a paper arguing that “psychology is fundamentally incompatible with hypothesis-driven theoretical science,” another paper finding that evidence-based medicine is more corporate gimmick than reliable science, a study that found psychiatrists deliver the worst-quality healthcare of any medical specialty, and more!
Mark Horowitz and David Taylor provide advice on how to tell the difference between antidepressant withdrawal and depression relapse.
According to patient reports, SSRI antidepressants most frequently lead to the subjective experience of emotional blunting.
A review of clinical practice guidelines for antidepressant discontinuation from across the English-speaking world reveals major pitfalls.
Health and wellbeing in young people are trending down in New Zealand. Are antidepressants to blame?
Drug regulators frequently approve drugs despite contradictory clinical trial results and without evidence of clinical benefits.
Researchers argue that we need a paradigm shift away from the biomedical model of mental illness to one informed by political action and common sense.
A review of research on antidepressant efficacy finds that an unfavorable risk-to-benefit ratio.
A meta-analysis published last month showed that psychotherapy has an enduring effect on depression—in contrast to depression pills.
Meta-analysis finds that the placebo run-in methodology reduces the placebo effect and finds antidepressants to be less useful.
Researchers developed a rating scale to better assess service users’ experiences tapering antidepressant and/or antipsychotic medication.
Jim van Os and Peter Groot discuss their paper: “Successful Use of Tapering Strips for Hyperbolic Reduction of Antidepressant Dose: A Cohort Study” published in the journal Therapeutic Advances in Psychopharmacology.
In May 2021, Cochrane published a network meta-analysis of depression pills for children. The abstract is misleading and reads like drug company marketing.
A researcher and service user Stevie Lewis recounts her own experience with antidepressant withdrawal and what she wishes her doctors knew.
Researchers again debunk the claim that the FDA black box warnings on antidepressants led to more suicides.
“Short and simple psychological programs can prevent people from relapsing when they stop their antidepressants.”